Biosimilar Act Trumps State Laws, Fed. Circ. Rules
The federal biosimilars act prevents drugmakers from using state laws to punish rivals for withholding information about copycat products, the Federal Circuit ruled Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article